NOT KNOWN FACTUAL STATEMENTS ABOUT SITUS JUDI MBL77

mutations presented The point that, as described down below, CLL therapy is based within the existence or absence of such mutations. The current consensus is, in addition to clonal mutations, subclonal mutations by using a variant allelic frequency starting from 5 to ten% (and thus below the brink of detection by common molecular tactics) is also d